С. Бунова, Н. А. Николаев, Е. В. Усачева, А. В. Нелидова, Л. А. Живилова, O. V. Zamakhina, S. Bunova, N. A. Nikolayev, E. Usacheva, A. V. Nelidova, L. Zhivilova
{"title":"THE POLYMORBIDITY AND THE EFFICIENCY OF STABLE CHD BETA-BLOCKERS TREATMENT IN THE POST-INFARCTION PERIOD","authors":"С. Бунова, Н. А. Николаев, Е. В. Усачева, А. В. Нелидова, Л. А. Живилова, O. V. Zamakhina, S. Bunova, N. A. Nikolayev, E. Usacheva, A. V. Nelidova, L. Zhivilova","doi":"10.18413/2075-4728-2019-42-2-180-193","DOIUrl":null,"url":null,"abstract":"The effect of co-and polymorbidity in increasing the heart rate (HR) pathology on achieving the target HR in the beta-adrenergic blockers (BAB) treatment of patients with stable coronary heart disease (CHD) after myo cardial infarction (MI) is studied. As part of an open, one-center, comparative study, 320 patients who had had MI more than 6 months ago were examined. They were counted on an outpatient HR and selected the optimal maximum tolerated dose of BAB in achieving HR, then were divided into 2 groups: 1) with a resting HR <60 per min. and 2) with resting HR> 60 per min. Co-and polymorbidity in increasing the HR pathology and its severity in the studied groups were identified and compared. Results: co-and polymorbidity in the increasing НАУЧНЫЕ ВЕДОМОСТИ Серия: Медицина. Фармация. 2019. Том 42, No 2 181 the HR pathology was significantly more common in patients with heart rate> 60 per 1 min .: smoking (p = 0.002); latent alcohol abuse (p = 0.024); carbohydrate metabolism disorders (p = 0.01); congestive heart failure (p = 0.01) with a functional class of 3 or more (p = 0.02); anemia (p = 0.04) and latent iron deficiency (p = 0.02); respiratory failure of 2 or more degrees (p = 0.03); high situational (p = 0.01) and high personal anxiety (p = 0.007). The number of co-and polymorbidity in the increasing HR pathologies in the group with HR> 60 in 1 min. were more: more patients with three (p = 0.008), four or more (p <0.001) of such diseases and condi tions at the same time. The Charlson comorbidity index was also higher in this group (p <0.05). Conclusion: in 55.9% of the studied patients it was not possible to reach the target HR, it was associated with an older age (p = 0.048) and the presence of co-and polymorbidity in the increasing HR pathology. Ключевые слова: стабильная ишемическая болезнь сердца, инфаркт миокарда, коморбидная патология, полиморбидная патология, целевая частота сердечных сокращений.","PeriodicalId":8785,"journal":{"name":"Belgorod State University Scientific bulletin Medicine Pharmacy","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Belgorod State University Scientific bulletin Medicine Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18413/2075-4728-2019-42-2-180-193","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The effect of co-and polymorbidity in increasing the heart rate (HR) pathology on achieving the target HR in the beta-adrenergic blockers (BAB) treatment of patients with stable coronary heart disease (CHD) after myo cardial infarction (MI) is studied. As part of an open, one-center, comparative study, 320 patients who had had MI more than 6 months ago were examined. They were counted on an outpatient HR and selected the optimal maximum tolerated dose of BAB in achieving HR, then were divided into 2 groups: 1) with a resting HR <60 per min. and 2) with resting HR> 60 per min. Co-and polymorbidity in increasing the HR pathology and its severity in the studied groups were identified and compared. Results: co-and polymorbidity in the increasing НАУЧНЫЕ ВЕДОМОСТИ Серия: Медицина. Фармация. 2019. Том 42, No 2 181 the HR pathology was significantly more common in patients with heart rate> 60 per 1 min .: smoking (p = 0.002); latent alcohol abuse (p = 0.024); carbohydrate metabolism disorders (p = 0.01); congestive heart failure (p = 0.01) with a functional class of 3 or more (p = 0.02); anemia (p = 0.04) and latent iron deficiency (p = 0.02); respiratory failure of 2 or more degrees (p = 0.03); high situational (p = 0.01) and high personal anxiety (p = 0.007). The number of co-and polymorbidity in the increasing HR pathologies in the group with HR> 60 in 1 min. were more: more patients with three (p = 0.008), four or more (p <0.001) of such diseases and condi tions at the same time. The Charlson comorbidity index was also higher in this group (p <0.05). Conclusion: in 55.9% of the studied patients it was not possible to reach the target HR, it was associated with an older age (p = 0.048) and the presence of co-and polymorbidity in the increasing HR pathology. Ключевые слова: стабильная ишемическая болезнь сердца, инфаркт миокарда, коморбидная патология, полиморбидная патология, целевая частота сердечных сокращений.